The rating according to our strategy based on Martin Zweig changed from 77% to 85% based on the firm’s underlying fundamentals and the stock’s valuation. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.ĪBBOTT LABORATORIES ( ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. Institutional Distribution Intelligence.Non-Traditional Exchanges & New Markets.Directors’ and Officers’ Questionnaires.
